SERIES B PREFERRED STOCK PURCHASEAGREEMENT Dated as of December 31, 2008 by and among BOND LABORATORIES, INC. and THE PURCHASERS LISTED ON EXHIBIT ASeries B Preferred Stock • January 23rd, 2009 • Bond Laboratories, Inc. • Medicinal chemicals & botanical products • New York
This SERIES B PREFERRED STOCK PURCHASEAGREEMENT (this “Agreement”), dated as of December 31, 2008 by and among Bond Laboratories, Inc., a Nevada corporation (the “Company”), and the purchasers listed on Exhibit A hereto (each a “Purchaser” and collectively, the “Purchasers”), for the purchase and sale of shares of the Company’s Series B Preferred Stock (the “Series B Preferred Stock”) and shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) by the Purchasers.
